Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy

Therapeutic Drug Monitoring

Volumn 34, Issue 1, 2012, Pages 4-10

  Schulz Juergensen, Sebastian ^a   Burdelski, Martin M ^a   Oellerich, Michael ^b   Brandhorst, Gunnar ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

iATP; immunosuppression; infection; pediatric liver transplantation; rejection

Indexed keywords

ACICLOVIR; ADENOSINE TRIPHOSPHATE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHYTOHEMAGGLUTININ; STEROID; TACROLIMUS;

ADD ON THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DISEASE MARKER; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; ENZYME SYNTHESIS; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFECTION RISK; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; SIDE EFFECT; STEROID THERAPY; VIRUS LOAD; VIRUS REACTIVATION;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; BIOLOGICAL MARKERS; CALCINEURIN; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE;

EID: 84856100808     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31823c5668     Document Type: Article

References (18)

1. Soltys KA, Mazariegos GV, Squires RH, et al. Late graft loss or death in pediatric liver transplantation: An analysis of the SPLIT database. Am J Transplant. 2007;7:2165-2171. (Pubitemid 47247040)
2. Kelly D, Jara P, Rodeck B, et al. Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: Randomised European multicentre trial. Lancet. 2004;364:1054-1061. (Pubitemid 39248664)
3. Rovira P, Mascarell L, Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr Med Chem. 2000;7:673-692. (Pubitemid 30366636)
4. Ahmed M, Venkataraman R, Logar AJ, et al. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(2) and CD8(+) peripheral blood T cells. Ther Drug Monit. 2001;23:354-362. (Pubitemid 32708918)
5. De Jonge H, Naesens M, Kuypers DR. New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: Possible consequences for therapeutic drug monitoring in solid organ transplantation. Ther Drug Monit. 2009;31: 416-435.
6. Quteineh L, Verstuyft C. Pharmacogenetics in immunosuppressants: Impact on dose requirement of calcineurin inhibitors in renal and liver pediatric transplant recipients. Curr Opin Organ Transplant. 2010;15: 601-607.
7. Kowalski RJ, Post D, Schneider MC, et al. Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003;17:77-88. (Pubitemid 36833776)
8. Cadillo-Chavez R, de Echegaray S, Santiago-Dephin EA, et al. Assessing the risk of infection and rejection in hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc. 2006; 38:918-920. (Pubitemid 44389510)
9. Kowalski RJ, Post DR, Mannon RB, et al. Assessing relative risks of infection and rejection: A meta-Analysis using an immune function assay. Transplantation. 2006;82:663-668. (Pubitemid 44395237)
10. Hooper E, Hawkins DM, Kowalski RJ, et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant. 2005;19:834-839. (Pubitemid 41748740)
11. Israeli M, Klein T, Sredni B, et al. ImmuKnow: A new parameter in immune monitoring of pediatric liver transplantation recipients. Liver Transpl. 2008;14:893-898. (Pubitemid 351895520)
12. Millan O, Sanchez-Fueyo A, Rimola A, et al. Is the intracellular ATP concentration of CD4+ T-cells a predictive biomarker of immune status in stable transplant recipients? Transplantation. 2009;88:S78-S84.
13. Israeli M, Ben-Gal T, Yaari V, et al. Individualized immune monitoring of cardiac transplant recipients by noninvasive longitudinal cellular immunity tests. Transplantation. 2010;89:968-976.
14. Reinsmoen NL, Cornett KM, Kloehn R, et al. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection. Transplantation. 2008;85:462-470.
15. Husain S, Raza K, Pilewski JM, et al. Experience with immune monitoring in lung transplant recipients: Correlation of low Immune function with infection. Transplantation. 2009;87:1852-1857.
16. Xue F, Zhang J, Han L, et al. Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. Transplantation. 2010;89:620-626.
17. Sampson VB, Dunn SP, Rymeskia B, et al. Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients. J Pediatr Surg. 2008;43:1134-1141. (Pubitemid 351814918)
18. Akhlaghi F, Gohh RY. The level of ATP production in mitogen-stimulated CD4+ lymphocytes is independent of the time of ingestion of immunosuppressive agents. Ther Drug Monit. 2010;32:116-117.